Effects of chronic n-hexane exposure on nervous system-specific and muscle-specific proteins.
Two kinds of nervous system-specific and muscle-specific proteins, enolase and S-100 protein, were quantitatively determined in peripheral nerves and skeletal muscles of rats chronically exposed to a neurotoxic solvent - n-hexane. Three groups of animals were exposed to n-hexane vapor at three different solvent concentrations (500 ppm, 1200 ppm, 3000 ppm) for 12 h/day, 7 days/week for 16 weeks. The body weight gain and motor nerve conduction velocity (MCV) in exposure groups show progressively concentration-dependent decreases compared to control values. Histopathological examination also demonstrates the degeneration of peripheral nerves in 3000 ppm- and 1200 ppm-exposed rats. The significant decrease in the amount of S-100 protein in peripheral nerves was observed not only in the high level exposure groups (3000 ppm and 1200 ppm), but also in the lowest level group (500 ppm), although the MCV and morphological examination remained unchanged at this level. In addition, the muscle-specific S-100 protein in 3000 ppm exposed rats' soleus also displayed a significant reduction. In contrast to this, however, enolase isozymes were not significantly changed by either dosage level in both nervous tissue and skeletal muscle. The experiment suggests that beta- and alpha-S-100 proteins which are specifically localized in nervous system and muscles, respectively, are more vulnerable than enolase isozymes under treatment with n-hexane, and may possibly serve as a specific indicator to evaluate the neurotoxic effects. Further research would be worthwhile to elucidate the role of the specific S-100 protein in evaluating the neurologic damage induced by various industrial chemicals.
Huang
J
J
Department of Hygiene, Nagoya University School of Medicine, Japan.
Kato
K
K
Shibata
E
E
Sugimura
K
K
Hisanaga
N
N
Ono
Y
Y
Takeuchi
Y
Y
D000818:Animals; D001835:Body Weight; D004594:Electrophysiology; D006586:Hexanes; D008297:Male; D009124:Muscle Proteins / Q000378:metabolism*; D009132:Muscles / Q000187:drug effects / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000378:metabolism*; D009422:Nervous System Diseases / Q000139:chemically induced / Q000378:metabolism; D009431:Neural Conduction / Q000187:drug effects; D010525:Peripheral Nerves / Q000187:drug effects / Q000378:metabolism; D010751:Phosphopyruvate Hydratase / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains
D006586:Hexanes; D009124:Muscle Proteins; D009419:Nerve Tissue Proteins; C026385:n-hexane; D010751:Phosphopyruvate Hydratase